Epithelial Ovarian Carcinoma research hub

EPITOME-1015-I: A phase I study to investigate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal adenocarcinoma, round cell liposarcoma and/or synovial sarcoma

This study is testing a new medicine, MDG1015, for the first time in people. It aims to see if it's safe and how well people tolerate it. The study is for certain types of cancer: ovarian, stomach/gullet, and two types of soft tissue sarcoma.